Effects of Descurainia sophia on Oxidative Stress Markers and Thirst Alleviation in Hemodialysis Patients: A Randomized Double-Blinded Placebo-Controlled Cross-Over Clinical Trial

Author:

Asgharpour Masoumeh1,Enayati Noora2,Rezaei Sadrabadi Mohammad3,Mohamadi Afrakati Mana4,Khavandegar Armin5ORCID,Mardi Parham5,Alirezaei Amirhesam6ORCID,Taherinia Ali7,Bakhtiyari Mahmood89ORCID

Affiliation:

1. Department of Nephrology, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran

2. Department of Phytochemistry, Medicinal Plants and Drug Research Institute, Shahid Beheshti University, Tehran, Iran

3. Department of Internal Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4. Department of Internal Medicine, Emam Ali Hospital, Alborz University of Medical Sciences, Tehran, Iran

5. Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran

6. Clinical Research and Development Center, Shahid Modarres Hospital, Department of Nephrology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

7. Department of Emergency Medicine, Alborz University of Medical Sciences, Karaj, Iran

8. Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran

9. Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Abstract

Background. Patients undergoing hemodialysis (HD) are regularly exposed to oxidative stress and inflammation and may suffer from thirst distress with no definitive treatment to address these complications. Descurainia sophia (DS) has been used to alleviate thirst in traditional Persian medicine. This study aimed to assess the effectiveness of DS on oxidation factors and thirst score in HD patients. Methods. This study was conducted on fifty-three HD patients referred to Tehran Shahid Modarres hospital. The patients were randomly divided into two groups: Group 1 received DS for six weeks, then underwent four weeks of washout period followed by six weeks of placebo treatment, while group 2 received placebo initially followed by treatment with DS. Biochemistry, malondialdehyde (MDA), and total antioxidant capacity (TAC) were measured in four phases: at the beginning, before washout, after washout, and at the end of the study. The patient’s body weight was recorded at the start of each session to assess interdialytic weight gain. Thirst scores also were measured using a visual analog scale. Results. A total of 53 patients, including 23 (43.4%) male and 30 (56.6%) female subjects, were included in the study. The results showed a reduction in thirst score ( p = 0.001 ), cholesterol levels ( p = 0.046 ), triglycerides (0.003), and MDA ( p < 0.001 ) following the four-week administration of DS treatment in HD patients. The mean levels of TAC were increased ( p < 0.001 ), and calcium, as well as Na+, remained unchanged ( p > 0.05 ). Also, a significant decrease in the patient’s weight was observed ( p value <0.001). This effect persisted after shifting to a placebo. However, the two groups had no significant difference ( p value = 0.539). Conclusion. DS powder-mixed syrup may benefit HD patients by facilitating free radical scavenging and alleviating thirst distress with minimal adverse effects. The seeds could therefore be utilized as a complementary therapy for hemodialysis patients.

Funder

Alborz University of Medical Sciences

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3